As of 2026-09-16, the Relative Valuation of Novavax Inc (NVAX) is (9.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.23 USD, the upside of Novavax Inc based on Relative Valuation is -206.5%.
The range of the Relative Valuation is (30.61) - 14.36 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.3x - 26.2x | 22.3x |
| Forward P/E multiples | 21.1x - 24.7x | 24.0x |
| Fair Price | (30.61) - 14.36 | (9.83) |
| Upside | -431.7% - 55.6% | -206.5% |
| Date | P/E |
| 2026-09-11 | -6.25 |
| 2026-09-10 | -6.17 |
| 2026-09-09 | -6.54 |
| 2026-09-08 | -6.76 |
| 2026-09-04 | -6.78 |
| 2026-09-03 | -6.86 |
| 2026-09-02 | -6.85 |
| 2026-09-01 | -6.72 |
| 2026-08-31 | -6.22 |
| 2026-08-28 | -6.15 |
| 2026-08-27 | -6.01 |
| 2026-08-26 | -6.11 |
| 2026-08-25 | -6.27 |
| 2026-08-24 | -5.88 |
| 2026-08-21 | -5.93 |
| 2026-08-20 | -5.59 |
| 2026-08-19 | -5.83 |
| 2026-08-18 | -5.26 |
| 2026-08-17 | -5.36 |
| 2026-08-14 | -5.34 |
| 2026-08-13 | -5.40 |
| 2026-08-12 | -5.28 |
| 2026-08-11 | -5.28 |
| 2026-08-10 | -5.24 |
| 2026-08-07 | -5.28 |
| 2026-08-06 | -5.14 |
| 2026-08-05 | -5.11 |
| 2026-08-04 | -5.08 |
| 2026-08-03 | -4.92 |
| 2026-07-31 | -4.86 |
| 2026-07-30 | -4.94 |
| 2026-07-29 | -4.87 |
| 2026-07-28 | -4.89 |
| 2026-07-27 | -4.97 |
| 2026-07-24 | -4.95 |
| 2026-07-23 | -5.19 |
| 2026-07-22 | -5.25 |
| 2026-07-21 | -5.36 |
| 2026-07-20 | -5.23 |
| 2026-07-17 | -5.45 |
| 2026-07-16 | -5.47 |
| 2026-07-15 | -5.60 |
| 2026-07-14 | -5.59 |
| 2026-07-13 | -5.91 |
| 2026-07-10 | -6.19 |
| 2026-07-09 | -6.24 |
| 2026-07-08 | -6.21 |
| 2026-07-07 | -6.28 |
| 2026-07-06 | -6.21 |
| 2026-07-02 | -6.47 |